Description: Tenofovir disoproxil aspartate (formerly known as CKD-390) is an antiretroviral drug acting as a nucleotide reverse transcriptase inhibitor to prevent and treat HIV/AIDS and to treat chronic hepatitis B. The active substance is tenofovir, while tenofovir disoproxil is a prodrug that is used because of its better absorption in the gut.

References: De Clercq E. Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF). Biochem Pharmacol. 2016 Apr 29. pii: S0006-2952(16)30069-7. doi: 10.1016/j.bcp.2016.04.015.

Related CAS #: 202138-50-9 (fumarate); 206184-49-8 (hydrate); 379270-37-8 (alafenamide); 206184-49-8 (hydrate); 1571075-19-8 (aspartate); 201341-05-1 Tenofovir dsoproxil); 1236287-04-9 (Tenofovir maleate); 1392275-56-7 (Tenofovir alafenamide hemifumarate); 379270-38-9 (Tenofovir alafenamide fumarate); 1464851-21-5 [(Z)-9-Propenyladenine; (Z)-Mutagenic Impurity of Tenofovir Disoproxil]; 1446486-33-4 [9-Propenyladenine; Mutagenic Impurity of Tenofovir Disoproxil; Tenofovir Impurity 2]; 1276030-80-8 (Tenofovir disoproxil maleate) 1453166-76-1 (Tenofovir disoproxil phosphate) 1637632-97-3 (Tenofovir disoproxil succinate)

纯度：≥98%

CAS：1571075-19-8